Orthopedic Stem Cell Use in the U.S. Projected to Rise as Competition in the Market Intensifies; Led by NuVasive (press release)
According to a recent report by iData Research, the buzz over orthopedic stem cells is reflected in their rapid growth. In 2014 alone, the orthopedic stem cell market grew by more than 17%.
According to a recently published report by iData Research , the orthopedic stem cell market was the fastest growing orthopedic biomaterial segment in the US. It aims to provide greater osteoinductive and osteogenesis properties compared to other bone grafts, therefore improving bone repair. These stem cells are currently only being used for spinal procedures, specifically lumbar and cervical indications. But the market may experience further growth as more competitors join the market and as education about stem cell use improves allowing other indications to become approved by the FDA.
“Orthopedic stem cells' higher average selling price is better tolerated by the commercialized nature of the spine market, explains Dr. Kamran Zamanian, CEO of iData. “As new stem cell products and innovations enter the market, prices should decline, which will aid in greater adoption a...
